A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
Adoptive immunotherapy using TCR gene-modified T-lymphocytes is an attractive strategy for targeting malignancies. However, TCR mispairings between endogenous and introduced TCR chains are a major concern, as they may induce mixed TCRs with unknown specificities and may reduce the expression of ther...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2012-01-01
|
| Schriftenreihe: | Molecular Therapy: Nucleic Acids |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2162253116301184 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
